Literature DB >> 12909647

Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection.

Zhijun Song1, Hong Wu1, Oana Ciofu1, Kok-Fai Kong1, Niels Høiby1, Jørgen Rygaard1, Arsalan Kharazmi1, Kalai Mathee1.   

Abstract

Pseudomonas aeruginosa is an opportunistic respiratory pathogen that accounts for most of the morbidity and mortality in cystic fibrosis (CF) patients. In CF-affected lungs, the bacteria undergo conversion from a non-mucoid to a non-tractable mucoid phenotype, due to overproduction of alginate. The effect of alginate production on pathogenicity was investigated by using an acute lung infection mouse model that compared a non-mucoid P. aeruginosa strain, PAO1, to its constitutive alginate-overproducing derivative, Alg(+) PAOmucA22, and an alginate-defective strain, Alg(-) PAOalgD. Bacterial suspensions were instilled into the left bronchus and examined 24 and 48 h post-infection. The highest bacterial loads and the most severe lung pathology were observed with strain Alg(-) PAOalgD at 24 h post-infection, which may have been due to an increase in expression of bacterial elastase by the mutant. Significantly lower lung and spleen bacterial loads were found in the two non-mucoid (PAO1 and Alg(-) PAOalgD) groups, compared to the mucoid Alg(+) PAOmucA22 group, between 24 and 48 h post-infection. The positive correlation between lung bacteriology and lung macroscopic pathology in the Alg(+) PAOmucA22 group suggests that alginate production not only impedes pulmonary clearing, but also results in severe lung damage. Positive correlations between IL12 levels and lung macroscopic pathology, and between IL12 and IFN-gamma levels in the Alg(+) PAOmucA22 group, suggested a possible contribution of these pro-inflammatory cytokines to tissue damage. No significant differences were found between the three groups in lung cytokine responses at 24 or 48 h post-infection. However, on comparison within each group at 24 and 48 h post-infection, a significant increase in the pro-inflammatory cytokine IFN-gamma was observed. Higher ratios of IFN-gamma/IL4 and IFN-gamma/IL10, but lower IL10 levels, were also found in all three groups. These results indicate a Th1-predominated immune response in these animals. Such cytokine responses could have aided the clearance of non-mucoid P. aeruginosa, but were not sufficient to alleviate infection by the mucoid variants. Alginate production may promote survival and persistence of this pathogenic micro-organism in the lung.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12909647     DOI: 10.1099/jmm.0.05122-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  27 in total

Review 1.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  Baoleri Lee; Janus A J Haagensen; Oana Ciofu; Jens Bo Andersen; Niels Høiby; Søren Molin
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 3.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms.

Authors:  Wang Hengzhuang; Hong Wu; Oana Ciofu; Zhijun Song; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

5.  Impact of alginate-producing Pseudomonas aeruginosa on alveolar macrophage apoptotic cell clearance.

Authors:  Charlie A McCaslin; Daniela N Petrusca; Gregory G Anderson; Irina Petrache; Christophe Poirier; Karina A Serban
Journal:  J Cyst Fibros       Date:  2014-07-12       Impact factor: 5.482

6.  Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F.

Authors:  Kathryn J Quigley; Catherine J Reynolds; Amelie Goudet; Eleanor J Raynsford; Ruhena Sergeant; Andrew Quigley; Stefan Worgall; Diana Bilton; Robert Wilson; Michael R Loebinger; Bernard Maillere; Daniel M Altmann; Rosemary J Boyton
Journal:  Am J Respir Crit Care Med       Date:  2015-06-01       Impact factor: 21.405

7.  Importance of the Exopolysaccharide Matrix in Antimicrobial Tolerance of Pseudomonas aeruginosa Aggregates.

Authors:  Lise Goltermann; Tim Tolker-Nielsen
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

8.  Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients.

Authors:  Thomas Bjarnsholt; Peter Østrup Jensen; Tim Holm Jakobsen; Richard Phipps; Anne Kirstine Nielsen; Morten Theil Rybtke; Tim Tolker-Nielsen; Michael Givskov; Niels Høiby; Oana Ciofu
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

9.  Functional characterization of AlgL, an alginate lyase from Pseudomonas aeruginosa.

Authors:  Emma K Farrell; Peter A Tipton
Journal:  Biochemistry       Date:  2012-12-13       Impact factor: 3.162

10.  Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis.

Authors:  Claus Moser; Maria Van Gennip; Thomas Bjarnsholt; Peter Østrup Jensen; Baoleri Lee; Hans Petter Hougen; Henrik Calum; Oana Ciofu; Michael Givskov; Søren Molin; Niels Høiby
Journal:  APMIS       Date:  2009-02       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.